Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

Aller à Demande

1. WO2020182927 - AGENTS DE LIAISON AU POTASSIUM DESTINÉS À ÊTRE UTILISÉS CHEZ DES PATIENTS SOUS HÉMODIALYSE

Note: Texte fondé sur des processus automatiques de reconnaissance optique de caractères. Seule la version PDF a une valeur juridique

[ EN ]

CLAIMS

1. A method for treatment of hyperkalemia in a hemodialysis patient comprising administering a potassium-binding agent to a patient in need thereof. 2. The method of claim 1, where the potassium -binding agent is a microporous zirconium silicate.

3. The method of claim 1, where the potassium -binding agent is Sodium Zirconium Cyclosilicate.

4. The method of claim 1, where the potassium -binding agent is administered on non-dialysis days.

5. The method of claim 3, where the potassium -binding agent is administered in a 5 gram dose.

6. The method of claim 3, where the potassium -binding agent is administered in a 10 gram dose.

7. The method of claim 3, where the potassium -binding agent is administered in a 15 gram dose.

8. The method of claim 1, where the potassium -binding agent is administered on non-dialysis days.

9. The method of claim 1, where the potassium -binding agent is a 2-fluoroacrylate-divinylbenzene-l,7-octadiene copolymer crosslinked in the salt or acid form.

10. The method of claim 1, where the 2-fluoroacrylate-divinylbenzene-l,7-octadiene copolymer crosslinked in the salt or acid form is patiromer sorbitex calcium.